BACKGROUND: Most clinical guidelines state that with early preterm premature rupture of membranes, obstetric and pediatric teams must share a realistic and individualized appraisal of neonatal outcomes with parents and consider their wishes for all decisions. However, we currently lack reliable and relevant data, according to gestational age at rupture of membranes, to adequately counsel parents during pregnancy and to reflect on our policies of care at these extreme gestational ages. OBJECTIVE: We sought to describe both perinatal and 2-year outcomes of preterm infants born after preterm premature rupture of membranes at 22e25 weeks' gestation. STUDY DESIGN: EPIPAGE-2 is a French national prospective population-based cohort of preterm infants born in 546 maternity units in 2011. Inclusion criteria in this analysis were women diagnosed with preterm premature rupture of membranes at 22e25 weeks' gestation and singleton or twin gestations with fetus(es) alive at rupture of membranes. Latency duration, antenatal management, and outcomes (survival at discharge, survival at discharge without severe morbidity, and survival at 2 years' corrected age without cerebral palsy) were described and compared by gestational age at preterm premature rupture of membranes. RESULTS: Among the 1435 women with a diagnosis of preterm premature rupture of membranes, 379 were at 22e25 weeks' gestation, with 427 fetuses (331 singletons and 96 twins). Median gestational age at preterm premature rupture of membranes and at birth were 24 (interquartile range 23e25) and 25 (24e27) weeks, respectively. For each gestational age at preterm premature rupture of membranes, nearly half of the fetuses were born within the week after the rupture of membranes. Among the 427 fetuses, 51.7% were survivors at discharge (14.1%, 39.5%, 66.8%, and 75.8% with preterm premature rupture of membranes at 22, 23, 24, and 25 weeks, respectively), 38.8% were survivors at discharge without severe morbidity, and 46.4% were survivors at 2 years without cerebral palsy, with wide variations by gestational age at preterm premature rupture of membranes. Survival at 2 years without cerebral palsy was low with preterm premature rupture of membranes at 22 and 23 weeks but reached approximately 60% and 70% with preterm premature rupture of membranes at 24 and 25 weeks. CONCLUSION: Preterm premature rupture of membranes at 22e25 weeks is associated with high incidence of mortality and morbidity, with wide variations by gestational age at preterm premature rupture of membranes. However, a nonnegligible proportion of children survive without severe morbidity both at discharge and at 2 years' corrected age.
Introduction
Early preterm premature rupture of membranes (PPROM), defined as PPROM at 22e25 weeks' gestation, occurs in <1% of pregnancies and is associated with a high rate of perinatal morbidity and mortality.
1e4 Fetuses exposed to early PPROM face increased risks of obstetric (placental abruption, cord prolapse, and infection) and fetal (pulmonary hypoplasia, limb deformities, prematurity, and in utero demise) 1, 3, 4 complications with short-and long-term potential adverse consequences.
With these high risks of extreme prematurity and severe disability, antenatal care requires considering the uncertainty about neonatal prognosis and the risks of severe maternal complications, particularly sepsis. Management options are induction of labor, either immediately 3 or in cases of severe oligohydramnios or chorioamnionitis, 5 or expectant management with antibiotics and with steroids once viability is reached. 3 Most clinical guidelines state that with early PPROM, obstetric and pediatric teams must share a realistic and individualized appraisal of neonatal outcomes with parents and consider their wishes for all decisions. 2, 3, 5 However, we currently lack reliable and relevant data, according to gestational age (GA) at PPROM, to adequately counsel parents during pregnancy and to reflect on our policies of care at these extreme GAs. Indeed, evidence-based data concerning periviable complications of pregnancy are scarce: available data are mostly from small retrospective studies, often restricted to women eligible for expectant management, which thus leads to overestimating neonatal survival. 2, 3, 6 We aimed to describe and quantify both perinatal and 2-year outcomes of preterm infants born after PPROM at 22e25 weeks' gestation, within a prospective population-based cohort at a national level.
Materials and Methods

Setting and data collection of the EPIPAGE-2 cohort study
This was a secondary analysis of EPIPAGE-2 (Etude épidémiologique sur les petits âges gestationnels 2), a prospective, national, population-based cohort study of preterm infants born in France in 2011. 7 All live births, stillbirths, and terminations of pregnancy (TOPs) at 22 0/7 e34 6/7 weeks' gestation (n ¼ 7804), whose parents had not declined to participate, were included in 25 French regions involving 546 maternity units. Only 1 region, accounting for 2% of all births in France, did not participate. The overall participation rate was 93%. The recruitment periods differed by GA at birth: 22e26 weeks (8 months), 27e31 weeks (6 months), and 32e34 weeks (5 weeks). Extremely preterm births (22e26 weeks) were recruited during a longer period because of their very low incidence and only a sample of moderate preterm births (32e34 weeks) was recruited. Maternal, obstetric, and neonatal data were collected from medical records following a standardized protocol. Full details of the cohort recruitment and data collection are reported elsewhere. 7 The EPIPAGE-2 cohort study was implemented to describe short-and long-term outcomes among preterm infants. For that purpose, in children included in follow-up, a detailed neurological and sensory examination was performed by the referring physician at 2 years' corrected age. 8 
Ethics
As required by French law and regulations, EPIPAGE-2 was approved by the national data protection authority (National Commission on Informatics and Liberty no. 911009), the appropriate ethics committees (Consultative Committee on the Treatment of Data on Personal Health for Research Purposes, reference no. 10.626), and the Committee for the Protection of People Participating in Biomedical Research (reference CPP SC-2873).
Participants
Our study population included all women diagnosed with PPROM at 22e25 completed weeks' gestation and fetuses alive at the time of PPROM. PPROM was defined as spontaneous rupture of membranes occurring at least 12 hours before birth. As recommended, the diagnosis was made by the attending obstetric staff based on maternal history and sterile speculum examination visualizing amniotic fluid leakage from the cervical os, with a diagnostic test if necessary.
3,5 Exclusion criteria were lethal malformations, triplets and quadruplets (to obtain a more homogeneous population), as well as multiple pregnancies with twinto-twin transfusion syndrome (that can be responsible for both iatrogenic PPROM related to fetoscopic selective laser photocoagulation and poorer neonatal outcomes). Differed births or with one of the babies ineligible for analysis were also excluded.
French guidelines and practices
Overall, recommended antenatal care of women with PPROM include expectant management, with antibiotics, corticosteroids from viability to 34 weeks' gestation and, if necessary, tocolysis and in utero transfer. 5 Magnesium sulfate was not routinely used for tocolysis or neuroprotection in 2011. According to French legislation, TOP on parental request can be provided at any time if the fetus is affected by a severe and incurable pathology or if maternal life is seriously jeopardized. With PPROM <24 weeks' gestation, guidelines from the National College of French Gynecologists and Obstetricians state that medical TOP should not be considered in the absence of oligohydramnios or chorioamnionitis and that all decisions should take into account parental wishes after adequate counseling. 5 
Assessment of the natural history of PPROM
The natural history of periviable PPROM was investigated by the latency period (the time elapsed from rupture to delivery), GA at birth, determined as the best obstetrical estimate combining last menstrual period and first-trimester ultrasonography assessment, and the specific complications of early PPROM. We focused on the following complications: severe oligohydramnios in the last measurement before delivery (ie, largest vertical pocket <2 cm or amniotic fluid index <5, with anhydramnios defined as amniotic fluid index ¼ 0), placental abruption, cord prolapse, fetal consequences of prolonged oligohydramnios (ie, pulmonary hypoplasia and/or limb deformities), and clinical chorioamnionitis. The diagnosis of clinical AJOG at a Glance Why was this study conducted? To provide reliable and relevant data related to the prognosis of preterm premature rupture of membranes (PPROM) at 22e25 weeks to adequately counsel parents during pregnancy and to reflect on our policies of care.
Key findings
Nearly half of the fetuses are delivered within the first week. PPROM at 22e25 weeks is associated with high incidence of perinatal mortality and morbidity, with wide variations by gestational age at PPROM. However, a nonnegligible proportion of children survive without severe morbidity both at discharge and at 2 years.
What does this add to what is known?
This study is the first to describe and quantify perinatal and 2-year outcomes of singletons and twins born after periviable PPROM, using data from a national prospective population-based cohort. The use of different inception points to report rates of survival is helpful in adapting information provided to parents when the gestational age of birth is not yet known.
ajog.org OBSTETRICS Original Research chorioamnionitis was not standardized in this observational cohort, but all relevant data were collected and allowed us to define clinical chorioamnionitis as maternal temperature 37.8 C (100 F) associated with any 2 of the following criteria: uterine tenderness, purulent or foul-smelling amniotic fluid, maternal tachycardia, fetal tachycardia, and maternal leukocytosis 15,000 cells/ mm 3 . Data to assess maternal outcomes, including infectious complications, were not exhaustive in the EPIPAGE-2 questionnaires and were thus not analyzed.
Antenatal management
We described antenatal care provided to women in terms of in utero transfer, treatments, and mode of delivery. Maternity wards were classified as type 3 when associated with a neonatal intensive care unit (NICU). Steroid treatment was considered when the mother received at least 1 injection of betamethasone.
Perinatal and 2-year outcomes
Perinatal outcomes included vital status, classified as TOP, antepartum stillbirth, death during labor or in the delivery room (after spontaneous preterm labor or induction of labor), death in the NICU, 9 and survival at discharge. We also investigated survival at discharge without severe morbidity (ie, without grade 3e4 intraventricular hemorrhage, 10 cystic periventricular leukomalacia, 11 stage II or III necrotizing enterocolitis, 12 stage 3 retinopathy of prematurity, 13 and/or laser treatment and severe bronchopulmonary dysplasia defined as requiring oxygen for at least 28 days in addition to the requirement of 30% oxygen and/or mechanical ventilator support or continuous positive airway pressure at 36 weeks' postmenstrual age 14 ). Z-score birthweights were calculated from EPOPé intrauterine growth curves corrected for sex and GA. 15 The third outcome was survival at 2 years' corrected age without cerebral palsy whatever the stage. Cerebral palsy was defined according to the diagnostic criteria of the Surveillance of Cerebral Palsy in Europe network. 16 We thought to report deafness and blindness as well but there were no cases in our population. 8 
Statistical analysis
We first compared characteristics and outcomes by type of pregnancy (single or multiple) and found no significant difference, especially concerning median GA at PPROM, latency, and GA at birth, except for tocolysis and spontaneous onset of labor, which were significantly more frequent in twins (Tables A.1 and A.2). Thereafter we analyzed singletons and twins together. We described natural history of PPROM, antenatal management, and perinatal outcomes overall, then compared them by week of GA at PPROM. Data are reported as percentages with 95% confidence intervals (CI) or medians with interquartile range (IQR). Medians of quantitative variables were compared by a nonparametric equality-ofmedians test. When comparing by week of GA, to account for the nonindependence of twins, we used generalized estimating equations to obtain P values, assuming an exchangeable correlation structure. 17 To account for the duration of the recruitment periods by GA at birth, a weighted coefficient was allocated to each individual (1 for births at 22e26 weeks, 1.346 for births at 27e31 weeks, and 7 for births at 32e34 weeks). Attrition is a key issue in longitudinal cohort studies. 8 In this analysis, the proportion of infants eligible but lost to follow-up was 17.7% of infants alive at 2 years' corrected age (8.2% of all fetuses included). We compared characteristics of eligible infants with and without follow-up and found no difference, except for low maternal age and low socioeconomic status that were associated with loss to follow-up (Table A. 3). In addition to complete-cases analysis, we performed multiple imputations with chained equations with a logistic regression imputation model for missing 
Flowchart of patients included in the study
Flow chart summarizes how sample size of analysis was reached. Original Research OBSTETRICS ajog.org binary data and a multinomial imputation model for missing categorical data. Imputation model variables included both those potentially predicting nonresponse and/or outcomes (type of maternity unit, maternal age and country of birth, socioeconomic status, parity, GAs at PPROM and at birth, latency duration, multiple pregnancy, in utero transfer, antenatal steroids and antibiotics, magnesium sulfate, tocolysis, clinical chorioamnionitis, cord prolapse, 
Results
Among the 1435 women with a diagnosis of PPROM, 379 were at 22e25 weeks' gestation, with 427 fetuses alive (331 singletons and 96 twins) ( Figure) . Pregnancy was complicated by PPROM at 22, 23, 24, and 25 weeks' gestation in 101 (21.4%), 95 (24.1%), 99 (24.0%), and 132 fetuses (30.5%), respectively. The overall population was 78% French or European, with a median age of 29 years (IQR 26e34), 91% lived with a partner and 51% were nulliparous, with no significant difference by GA at PPROM (Table A. 4) .
Median GA at PPROM was 24 (IQR 23e25) weeks. Latency duration ranged from 0.5e145 days. Latency duration did not differ by week of GA at PPROM, nor did latency >2, 7, or 14 days (Table 1) . Whatever the GA at PPROM, nearly half of the fetuses were born within the first week of latency. Consequently, GA at birth significantly increased with GA at PPROM ( We found major differences in the obstetric management by GA at PPROM (Table 1) . More than 95% of infants were .68
All percentages obtained with complete-cases analysis, denominators can vary slightly according to missing data, namely for survival at discharge without severe morbidity (9 missing data).
CI, confidence interval; GA, gestational age; NICU, neonatal intensive care unit; PPROM, preterm premature rupture of membranes.
a Survival at discharge without grades 3e4 intraventricular hemorrhage, cystic periventricular leukomalacia, stages II or III necrotizing enterocolitis, stage 3 retinopathy of prematurity, and/or laser treatment and severe bronchopulmonary dysplasia. born in a type 3 maternity unit with PPROM at 24 or 25 weeks vs 58% and 78% with PPROM at 22 and 23 weeks. Accordingly, rates of in utero transfer were 2-to 3-fold higher >24 weeks. Most fetuses were exposed to antenatal steroids and cesarean delivery when PPROM occurred after the threshold considered for neonatal resuscitation in France in 2011 (24 weeks). The use of antenatal antibiotics, mainly amoxicillin and third-generation cephalosporins, was lower at 22 weeks (81% vs >92% afterwards). Causes and indications for delivery were mainly spontaneous onset of labor (62.2%) and induction of labor or cesarean delivery for clinical chorioamnionitis (18.5%).
With PPROM at 22e25 weeks, pregnancy outcomes were TOP (10 fetuses, 2.0%), antepartum stillbirth (21 fetuses, 5.6%), death during labor (81 fetuses, 16.6%), death in the delivery room (58 fetuses, 12.0%), death in the NICU (56 infants, 12.1%), or discharge alive (201 infants, 51.7%), with significant differences by GA at PPROM (Figure and  Table 2 ). TOPs were mostly performed for the earliest cases of PPROM (7, 1, 2, and 0 TOPs with PPROM at 22, 23, 24, and 25 weeks, respectively) complicated by anhydramnios and/or chorioamnionitis. Stillbirths and deaths in the delivery room were mainly related to specific complications of PPROM (clinical chorioamnionitis, oligohydramnios, placental abruption, or cord prolapse) or spontaneous delivery <24 weeks. Deaths in the NICU occurred within the first week for 41% and within the first month for 84% of deceased children. These deaths were mostly related to respiratory failure (38%), central nervous system injury (23%), or infection (14%).
Among the 315 liveborn infants, 68.2% survived until discharge, 51.6% survived until discharge without severe morbidity (38.8% of all fetuses), and 58.9% were survivors at 2 years' corrected age without cerebral palsy (43.4% of all fetuses). Overall, 13 infants had cerebral palsy (1, 1, 7, and 4 with PPROM at 22, 23, 24, and 25 weeks, respectively) but none had visual or auditory impairment. When considering all fetuses or liveborn infants, rates of survival, survival at discharge without severe morbidity, and survival at 2 years' corrected age without cerebral palsy significantly improved with increased GA at PPROM (Tables 2 and 3 ). For example, among all fetuses, rates of survival at discharge were 14.1%, 39.5%, 66.8%, and 75.8% with PPROM at 22, 23, 24, and 25 weeks, respectively. However, when focusing on survivors at discharge or survivors at 2 years CA, survival at discharge without severe morbidity or survival at 2 years' corrected age without cerebral palsy did not differ by GA at PPROM (Tables 2 and 3 ).
Comment
Main findings
This descriptive study shows that with PPROM at 22e25 weeks' gestation, overall and for each GA at PPROM, 
Strengths and limitations
The strengths of our study include a large sample of singletons and twins born preterm after PPROM at 22e25 weeks, which allowed for reporting characteristics and outcomes stratified by week of GA at PPROM, and follow-up at 2 years' corrected age. Because singletons and twins have similar latency durations and outcomes, our findings are relevant for both types of pregnancies, even though the prognosis could slightly differ between twins with intact or ruptured membranes. Unlike all published studies, 2,4,18e20 our sample stems from a prospective population-based cohort at a national level, thereby reflecting the diversity of antenatal management and outcomes in real-life practices. Moreover, accounting for all pregnancy outcomes when estimating neonatal prognosis allows for providing realistic figures that do not overestimate the chances of survival. The use of different inception points and thus denominators to report rates of survival is helpful in adapting information provided to parents during pregnancy when the GA of birth is not yet known. 21 Finally, the use of standardized definitions for outcomes allows for comparison with other international studies or cohorts. 21 The main limitation of this study is the proportion of missing data related to loss to follow-up at 2 years' corrected age, although attrition was moderate in relation to the cohort size and its geographical extent. 8 Appropriate statistical methods, with multiple imputations, allowed for accounting for missing data and obtaining nonbiased estimators. Another limitation, due to the design of the EPIPAGE-2 cohort, involves left truncation and rightcensoring of the sample at 34 6/7 weeks. 22 We avoided left truncation by including women with both PPROM and delivery from 22 weeks. Concerning rightcensoring, we likely missed the cases of PPROM at 22e25 weeks for fetuses delivered at 35 weeks. We assume that such cases are exceptional and have a favorable neonatal prognosis. Their noninclusion leads to a very slight underestimation of the chances of survival or disease-free survival. A disadvantage of these population-based data is that we are limited in investigating precisely the medical teams' willingness to provide antenatal active care (eg, antenatal steroids or performing a cesarean delivery), which can change as the pregnancy progresses. Moreover, some specific complications, namely pulmonary hypoplasia, are likely underdiagnosed as autopsies were not systematically performed to determine the cause of fetal or neonatal death.
Interpretation
Because of the high risks of extreme prematurity and severe disability, a key point in antenatal care is to adequately inform parents facing PPROM at 22e25 weeks and to consider their wishes in all decisions. 1, 3, 5, 23, 24 However, in this context, the information given to parents and the resulting management decisions depend very little on individual socioeconomic and clinical characteristics (except for GA) but are largely influenced by the institution and the practitioner who gives the information.
24e28 There is indeed great variability in how caregivers understand the prognosis of early PPROM, including neurodevelopmental impairment, and their willingness to propose active management. 26 This variability can be explained by significant variations in published rates of survival with early PPROM, leaving practitioners with a great uncertainty.
Indeed, reported survival after early PPROM ranges from 20e85%, survival without severe morbidity from 20e70%, and cerebral palsy from 0e10%. 2,4,6,18e20 Many reasons account for these variations. Selection bias, related to exclusion of women electing TOP or immediate induction of labor as well as women not eligible for expectant management or related to preadmission bias in tertiarycare referral centers, leads to overestimating latency durations and survival rates. 2,4,6,18e20 Ranges of GA at PPROM are wide and differ widely across studies; hence, overall nonstratified results do not allow for appropriate comparisons. Small sample sizes do not provide precise estimations. 2, 6, 20 Finally, published studies feature a retrospective design over 5e15 years, 6 ,18,20 but medical practices may have evolved and mortality rates may decrease. 29 Therefore, comparing our findings with previous publications is challenging. 21 We report high rates of mortality and morbidity when preterm births occur following early PPROM. Most children will be delivered extremely preterm, and their immaturity and fragility are major risk factors of adverse outcomes. The frequency of the other obstetric complications (placental abruption, cord prolapse, and chorioamnionitis) is lower than or similar to that previously described. 2, 6, 19, 20 With PPROM at 22e25 weeks' gestation, perinatal outcomes appear to be influenced by medical practices, which are themselves affected by the resuscitation threshold considered in France in 2011 (24 weeks). 24, 28, 30, 31 This hypothesis requires further investigation.
Because French guidelines about management of women with PPROM are broadly similar to those of other countries, our results may be generalizable to most developed countries with similar practices and are relevant to question the strategies of management of early pregnancy complications. 32 Improving the prognosis of these pregnancies probably requires a rethinking of care policies in a multidisciplinary way, involving obstetricians, neonatologists, care networks, parent associations, and policy makers.
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Conclusion
Following PPROM, both parents and professionals are left with a great deal of uncertainty regarding the evolution of pregnancy, complications, and fetal and neonatal prognosis. Our findings on the prognosis of PPROM at 22e25 weeks, based on prospective, population-based data at a national level, provide new insights that can be used as a support for counseling parents, especially during pregnancy when the GA of birth is not yet known. The impact of the practitioner's decisions on the prognosis should lead to homogenize and optimize the antenatal management practices. n 
